Design, synthesis and biological evaluation of novel quinazoline-derived EGFR/HER-2 dual-target inhibitors bearing a heterocyclic-containing tail as potential anti-tumor agents

Authors:

Abstract
No abstract available
Funding Information
  • National Natural Science Foundation of China (82103998)
  • Department of Science and Technology of Liaoning Province (2023JH2/20200171)

This publication has 37 references indexed in Scilit: